ENSC Stock Analysis: Buy, Sell, or Hold?
ENSC - Ensysce Biosciences, Inc. Common Stock
$0.61
-0.10 (-14.10%)
▼
5d:
-28.01%
30d:
-35.14%
90d:
-72.03%
WAIT
LOW Confidence
Last Updated: February 3, 2026
Earnings: Mar 09, 2026
Get Alerted When ENSC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ENSC is down 28.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: ENSC is down 28.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ENSC is currently trading at $0.61, which is considered oversold relative to its 30-day fair value range of $0.78 to $1.01.
Technical Outlook: Technically, ENSC is in a strong downtrend. Immediate support is located at $0.58, while resistance sits at $0.94. Short-term momentum is weak, with the stock down 14.1% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $19.23 (+3053.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ENSC is in a strong downtrend. Immediate support is located at $0.58, while resistance sits at $0.94. Short-term momentum is weak, with the stock down 14.1% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $19.23 (+3053.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$0.78 -
$1.01
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-14.1%)
- BULLISH: Trading 3053.2% below Wall St target ($19.23)
- WARNING: Recommendation downgraded due to -28.0% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$0.78 -
$1.01
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$0.59
Resistance Level
$0.94
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-0.27
Wall Street Target
$19.23
(+3053.2%)
Revenue Growth (YoY)
-85.6%
Profit Margin
-244.5%
Last updated: February 04, 2026 1:33 AM ET
Data refreshes hourly during market hours. Next update: 2:33 AM
Data refreshes hourly during market hours. Next update: 2:33 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ENSC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$91 | 61 BUY |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$89 | 62 BUY |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$215 | 58 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$217 | 59 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
BUY
20 analysts |
$31 | 60 BUY |
